Skip to content

A Multicenter Real-world Study of Screening of Cervical Cancer Based on Photoelectric Detection

A Multicenter Real-world Study of Screening of Cervical Cancer Based on Photoelectric Detection

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06481930
Enrollment
20000
Registered
2024-07-01
Start date
2024-07-31
Completion date
2026-07-31
Last updated
2024-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Grade Squamous Intraepithelial Lesions, Low Grade Squamous Intraepithelial Lesions, Uterine Cervical Cancer

Brief summary

The main purpose of this study is to explore the accuracy and clinical value of fluorescent photoelectric cervical lesion image detector as a screening and shunt tool for cervical lesions through a multi-center, large-sample real-world study with histopathology as the gold standard. The secondary purpose of the study was to verify the coincidence of the fluorescent photoelectric cervical lesion image detector with traditional colposcopic chemical staining. This study is expected to include 20,000 participants with definite histological results, and compare the specificity and sensitivity, negative predictive value and positive predictive value of three cervical lesion screening methods, such as fluorescent photoelectric cervical lesion image detector, HPV nucleic acid detection and cytology detection. The advantages and disadvantages of fluorescent photoelectric cervical disease image detector, HPV nucleic acid detection and cytology examination were analyzed, and their application scenarios were provided to provide evidence-based medical support for the establishment of comprehensive prevention and treatment system of cervical cancer suitable for China's national conditions.

Interventions

The enrolled patients underwent fluorescence photoelectric cervical lesion image detection, followed by colposcopy and biopsy to obtain histopathological results. The results of fluorescence photoelectric image detection were compared with histopathological results, and at the same time compared with HPV and TCT results at the time of enrollment.

Sponsors

Lei Li
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* 1\. Age ≥ 18 years old, ≤ 65 years old, with a complete cervix without deformity. * 2\. Have clear cervical cancer screening results, meet HPV16/18 (+) or high-risk HPV (+), and cervical cytology results ≥ ASC-US. * 3\. Fully informed and agreed to participate in the study. * 4\. No history of cervical cancer disease and cancer in other parts.

Exclusion criteria

* 1\. Cannot meet all Inclusion Criteria. * 2\. There is clear immunosuppression, such as HIV infection or organ transplantation, etc., and the vagina or cervix is in the acute inflammation stage。 * 3\. There are serious bleeding diseases or photosensitive diseases such as abnormal coagulation.

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of tissue lesion screening based on photoelectric detectionThe data collection time for each subject is approximately 7 days, starting from the day of each subject's enrollment and ending when the pathology report of the cervical tissue biopsy under colposcopy is issued.The sensitivity, specificity, positive predictive value and negative predictive value of fluorescence photoelectric cervix lesion image detector were calculated by using CIN 2 + as the gold standard determined by histopathology, and compared with those of HPV and TCT.

Countries

China

Contacts

Primary ContactLei Li, M.D.
lileigh@163.com8613911988831

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026